|Articles|November 1, 2022
Supplements and Featured Publications
- Biosimilars for Immune-Mediated Inflammatory Diseases: 2022 Update
- Volume 28
- Issue 12
What are the current challenges to wider biosimilar use in the United States?
Plain Language Summary
Advertisement
Plain Language Summary
Click the image to open in a new window.
Articles in this issue
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Judge Denies Preliminary Injunction in Medicaid Work Requirements Case
2
FDA Panel Backs 6 Peptides for Compounding
3
AHRQ Grant Freeze Halts Patient Safety Research Nationwide
4
FDA Advisory Panel Votes Against Approval of Deramiocel for DMD
5